September 20, 2024 Exploring Key Strategies for Scaling Up MCM Manufacturing at the i-MCM-Net Partners Meeting CEO DCVMN Advocacy developingcountries
May 23, 2024 The Pandemic Agreement: A Bridge to Nowhere or North Star to Access and Global Health Security? COVID-19 developingcountries GlobalHelath
May 8, 2024 DCVMN Board at the 8th International Symposium on Immunobiologicals in Rio de Janeiro Brazil DCVMN Board developingcountries Vaccines & immunization WeConnectToProtect
April 25, 2024 DCVMN CEO Inaugurating the Vaccine World Forum in Pune CEO developingcountries Vaccines & immunization WeConnectToProtect
April 11, 2024 DCVMN Board at the World Vaccine Congress DCVMN Advocacy DCVMN Board developingcountries Vaccines & immunization
April 3, 2024 DCVMN CEO Engagements in Addis Ababa Africa CEO DCVMN Advocacy developingcountries WeConnectToProtect
March 14, 2024 DCVMN Joint Statement with IFPMA and Trade Associations on Biopharmaceutical Industry Commitments DCVMN Advocacy developingcountries Statement WeConnectToProtect
August 2, 2023 Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report access DCVMN AGM developingcountries manufacturing sustainability vaccinedevelopment Vaccines